Detalhe da pesquisa
1.
Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy.
Immunity;
53(4): 824-839.e10, 2020 10 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33053331
2.
Eomes-dependent mitochondrial regulation promotes survival of pathogenic CD4+ T cells during inflammation.
J Exp Med;
221(2)2024 Feb 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38189779